Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Tilles

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Allergy and Clinical Immunology|July 2, 2013
A holistic view on dermatitis: patch testing should be considered in patients with atopic dermatitis. ReplyLynda C Schneider, Stephen Tilles,
The Journal of Allergy and Clinical Immunology|July 14, 2025
Allergen deficiencies in a commonly used protocol for peanut oral immunotherapyStephanie C Filep, Stephen Tilles, Martin D Chapman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 13, 2024
Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2500 children with peanut allergyMichele Jara, Ekaterina Walker, Stephen Tilles, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergyJ Andrew Bird, Caroline Nilsson, Kari Brown, et al.
Plos One|December 3, 2020
A study to assess current approaches of allergists in European countries diagnosing and managing children and adolescents with peanut allergyVibha Sharma, Jennifer Jobrack, Wendy Cerenzia, et al.
Allergy and Asthma Proceedings|May 25, 2019
Current management and use of oral immunotherapy in the United States for patients with peanut allergyMichael S Blaiss, Stephen Tilles, Daniel Petroni, et al.
The Journal of Allergy and Clinical Immunology|February 5, 2013
Atopic dermatitis: a practice parameter update 2012Lynda Schneider, Stephen Tilles, Peter Lio, et al.
Allergy|November 20, 2020
The global burden of illness of peanut allergy: A comprehensive literature reviewJay A Lieberman, Ruchi S Gupta, Rebecca C Knibb, et al.
Allergy and Asthma Proceedings|June 25, 2009
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitisMichael A Kaliner, William Storms, Stephen Tilles, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 4, 2023
Real-world experience of pediatric patients treated with peanut (Arachis hypogaea) allergen powder-dnfpJay Portnoy, Jodi Shroba, Stephen Tilles, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology|July 2, 2013
A holistic view on dermatitis: patch testing should be considered in patients with atopic dermatitis. ReplyLynda C Schneider, Stephen Tilles,
The Journal of Allergy and Clinical Immunology|July 14, 2025
Allergen deficiencies in a commonly used protocol for peanut oral immunotherapyStephanie C Filep, Stephen Tilles, Martin D Chapman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 13, 2024
Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2500 children with peanut allergyMichele Jara, Ekaterina Walker, Stephen Tilles, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergyJ Andrew Bird, Caroline Nilsson, Kari Brown, et al.
Plos One|December 3, 2020
A study to assess current approaches of allergists in European countries diagnosing and managing children and adolescents with peanut allergyVibha Sharma, Jennifer Jobrack, Wendy Cerenzia, et al.
Allergy and Asthma Proceedings|May 25, 2019
Current management and use of oral immunotherapy in the United States for patients with peanut allergyMichael S Blaiss, Stephen Tilles, Daniel Petroni, et al.
The Journal of Allergy and Clinical Immunology|February 5, 2013
Atopic dermatitis: a practice parameter update 2012Lynda Schneider, Stephen Tilles, Peter Lio, et al.
Allergy|November 20, 2020
The global burden of illness of peanut allergy: A comprehensive literature reviewJay A Lieberman, Ruchi S Gupta, Rebecca C Knibb, et al.
Allergy and Asthma Proceedings|June 25, 2009
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitisMichael A Kaliner, William Storms, Stephen Tilles, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 4, 2023
Real-world experience of pediatric patients treated with peanut (Arachis hypogaea) allergen powder-dnfpJay Portnoy, Jodi Shroba, Stephen Tilles, et al.
Pageof 3